Neuromodulation Devices: World Market Prospects 2013-2023

  • January 2013
  • -
  • Visiongain
  • -
  • 125 pages

Report Details

Neuromodulation is one of the fastest growing sectors of the medical device market. Neuromodulation is a rapidly evolving medical technique that provides symptomatic relief through the alteration, or modulation, of nerve system function. It works by either stimulating nerves to produce a natural biological response or by applying small doses of pharmaceutical agents directly to the site of action.

The market has significant potential for growth with the increasing global burden of neurological and cardiovascular disorders, especially in the emerging economies. The growth in emerging markets such as India andChina will be driven by an aging population that will increase demand for newer treatment options for age-related diseases. India's expanding economy is likely to see an increased wealth among the population, specifically within the middle class, which will cause an increased adoption of westernised lifestyles. Diseases such as obesity and coronary heart disease will therefore become more prevalent. The neuromodulation devices market in the emerging economies will also benefit from a rise in demand for non-invasive treatment options and medical tourism. Growth in this market will also be driven by the approval and launch of neuromodulation devices that are more effective and involve a more simplified, less-invasive implantation procedure.

Neuromodulation Devices: World Market Prospects 2013-2023 analyses the top 4 companies involved in the neuromodulation devices market. This report also provides sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis of the overall neuromodulation devices market. There are 75 tables and figures included. The result is comprehensive profiles on the leading companies operating in the neuromodulation devices market with detailed analyses and informed opinion to benefit your work. Visiongain has determined that the value of the global Neuromodulation Devices Market will reach $12.45bn in 2023.

What makes this report unique?

Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national market forecasts from 2012-2023 - all highlighting key business opportunities.

Why you should buy Neuromodulation Devices: World Market Prospects 2013-2023

• 111 pages of comprehensive analysis
• 2 Exclusive Visiongain interviews with experts from-
- Cochlear Ltd
- a US-based Medical Device Company (views provided anonymously)
• 75 tables, charts, and graphs
• Neuromodulation Device market forecasts between 2012-2023
• 3 Neuromodulation Device submarket forecasts from 2012-2023
- Spinal Cord Stimulation (SCS)
- Deep Brain Stimulation (DBS)
- Vagus Nerve Stimulation (VNS)
• A SWOT analysis
• Several leading companies identified and 4 profiled -
- Medtronic
- St. Jude Medical
- Boston Scientific
- Cyberonics

You can order this report today

Gain an understanding of the overall neuromodulation devices market and the leading companies operating in this market by ordering Neuromodulation Devices: World Market Prospects 2013-2023.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Table Of Contents

Table of Contents

1. Executive Summary
1.1 Sector Highlights
1.2 Aim, Scope and Format of the Report
1.3 Chapter Outline
1.4 Research and Analysis Method
1.5 Glossary of Terms Related to the Report

2. An Introduction to Neuromodulation
2.1 Neuromodulation
2.2 Techniques Used in Neuromodulation
2.2.1 Electrical Stimulation Techniques
2.2.1.1 Brain and Spinal Cord Therapies
2.2.1.2 Cranial Nerve Stimulation
2.2.1.3 Functional Electrical Stimulation
2.2.2 Pharmacological Therapy
2.3 Application of Neuromodulation
2.3.1 Pain
2.3.1.1 Neuromodulation in The Management of Pain
2.3.2 Depression
2.3.2.1 Neuromodulation in The Management of Depression
2.3.3 Epilepsy
2.3.3.1 Neuromodulation in The Management of Epilepsy
2.3.4 Urological Disorders: Overactive Bladder and Urinary Incontinence
2.3.4.1 Neuromulation in The Management of Urinary Incontinence
2.3.5 Hearing Disorders: Profound Deafness
2.3.5.1 Neuromodulation in The Management of Impaired Hearing
2.3.6 Cardiac Disorders: Arrhythmias and Angina
2.3.6.1 Neuromodulation in The Management of Cardiac Disorders
2.3.7 Parkinson's Disease
2.3.7.1 Neuromodulation in The Management of Parkinson's Disease

3. The Global Neuromodulation Devices Market, 2011-2023
3.1 The Global Medical Device Market, 2011
3.1.1 The Global Neurology Devices Market, 2011
3.2 The Global Neuromodulation Devices Market, 2011
3.3 The Global Neuromodulation Devices Market Forecast, 2013-2023
3.4 Neuromodulation Devices: Industry Trends, 2013-2023

4. Neuromodulation Devices Market Sectors: Spinal Cord Stimulation
4.1 Spinal Cord Stimulation (SCS)
4.2 SCS Market Forecast, 2013-2023
4.3 Spinal Cord Stimulation: Industry Trends, 2013-2023
4.4 Companies and Products
4.4.1 Medtronic
4.4.2 Boston Scientific
4.4.3 St. Jude Medical (SJM)
4.4.4 Nevro

5. Neuromodulation Devices Market Sectors: Deep Brain Stimulation
5.1 Deep Brain Stimulation (DBS)
5.2 DBS Market Forecast, 2013-2023
5.3 Deep Brain Stimulation: Industry Trends, 2013-2023
5.4 Companies and Products
5.4.1 Medtronic
5.4.2 St. Jude Medical

6. Neuromodulation Devices Market Sectors: Vagus Nerve Stimulation
6.1 Vagus Nerve Stimulation (VNS)
6.2 VNS Market Forecast, 2013-2023
6.3 Vagus Nerve Stimulation: Industry Trends, 2013-2023
6.4 Companies and Products
6.4.1 Cyberonics
6.4.2 CerebralRx (a spin-off of BioControl Medical)
6.4.3 EnteroMedics

7. The Leading Neuromodulation Device Manufacturers, 2011
7.1 Few Players Dominate the Market
7.2 Neuromodulation Device Market: Breakdown By Company, 2011
7.3 Medtronic
7.3.1 Sales and Recent Performance Analysis, 2011
7.3.1.1 Restorative Therapies
7.3.2 Medtronic Geographic Sales
7.3.3 Medtronic News
7.3.3.1 Expanding Into Sacral Neuromodulation
7.3.3.2 Adaptive Spinal Neuromodulation
7.4 St. Jude Medical (SJM)
7.4.1 Sales and Recent Performance Analysis, 2011
7.4.1.1 Cardiac Rhythm Management/Neuromodulation (CRM/NMD)
7.4.2 SJM Geographic Sales
7.4.3 SJM News
7.4.3.1 Peripheral Nerve Stimulation (PNS)
7.5 Boston Scientific
7.5.1 Sales and Recent Performance Analysis, 2011
7.5.2 Boston Scientific Geographic Sales
7.5.3 Boston Scientific News
7.5.3.1 Advancements in Deep Brain Stimulation (DBS) Technology
7.6 Cyberonics
7.6.1 Sales and Recent Performance Analysis, 2011
7.6.2 Cyberonics Geographic Sales
7.6.3 Cyberonics News
7.6.3.1 Strengthening VNS Technology Through Investment
7.7 Other Neuromodulation Device Manufacturers

8. Leading National Neuromodulation Devices Market, 2013-2023
8.1 Regional Breakdown of The Global Neuromodulation Devices Market, 2011
8.2 The Global Neuromodulation Devices Market: Regional Forecast, 2011-2023
8.3 The US Market
8.4 The European Ma

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - Global Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cance ...

Analysis of the Global Infectious Disease Diagnostics Market

Analysis of the Global Infectious Disease Diagnostics Market

  • $ 10 000
  • Industry report
  • September 2014
  • by Frost & Sullivan

Molecular Methods Present Significant Opportunities This deliverable provides research and analysis of the global infectious disease diagnostics market. It includes an in-depth analysis of revenue forecast ...

Global Mobile Healthcare Market Devices, Applications, Services Industry Size, Analysis, Market Report, Share, Growth, Trends and Forecast 2014-20

Global Mobile Healthcare Market Devices, Applications, Services Industry Size, Analysis, Market Report, Share, Growth, Trends and Forecast 2014-20

  • $ 7 000
  • Industry report
  • November 2014
  • by Occams

According to WHO approximately 17.3 million people die annually due to CVD and the condition is responsible for 30 percent of the global deaths. Also, 80 percent of CVD deaths take place in low and middle ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.